Skip to main content
SIU Annual Conference Main banner
 
Presentation Icons
Surgery Day
Surgery Day
Bench-to-Bedside
Bench-to-Bedside
SIU@U
SIU@U
    Session Type: B2B

    7th B2B Uro-Oncology: GU Cancers Triad Meeting - BLADDER CANCER

    Friday, October 31, 2025
    10:00 - 11:45 GMT+0

    Bench-to-Bedside SIU@U

    This educational programme is supported by:
    B2B Presenting Sponsors: Daiichi-Sankyo | AstraZeneca, Johnson & Johnson
    B2B Contributing Sponsors: Bristol Myers Squibb, CG Oncology, Ferring Pharmaceuticals, Merck Sharp & Dohme LLC, Novartis AG

      Moderator(s)

    • Peter Black

      Professor
      University of British Columbia, Canada

    B2B Scientific Programme Committee: Peter Black, Canada / Caroline Moore, United Kingdom / Simon Tanguay, Canada

    Learning Objectives :

    At the end of this session, attendees should be able to:
    • Evaluate the benefits, risks, and limitations of various treatment options across the management continuum in prostate cancer, bladder cancer, and kidney cancer.
    • Recognize the role of imaging and genetic markers in guiding treatment decision-making.
    • Analyze the efficacy and safety of emerging therapeutic approaches for the management of GU cancers based on current clinical data.
    • Recall strategies to identify, manage, and mitigate adverse events related to systemic treatment.
    • Discuss the importance of personalized medicine, based on treatment costs and patient preference, while minimizing toxicity and maximizing efficacy.

    Presentations:

    • 10:00 - 10:05 GMT+0
      Welcome and Introductions

      Co-chair: Peter Black – University of British Columbia

      Co-chair: Simon Tanguay – McGill University

    • 10:05 GMT+0
      Debate: Immune Checkpoint Blockade Plus BCG Is the New Standard First-line Therapy for High-risk NMIBC

      Moderator: Peter Black – University of British Columbia

    • 10:05 - 10:13 GMT+0
      Pro

      Speaker: Kilian Martin Gust – Austria

    • 10:13 - 10:21 GMT+0
      Con

      Speaker: Param Mariappan – The University of Edinburgh

    • 10:21 - 10:30 GMT+0
      Discussions and Q&A

      Speaker: Param Mariappan – The University of Edinburgh

      Speaker: Kilian Martin Gust – Austria

      Moderator: Peter Black – University of British Columbia

    • 10:30 GMT+0
      Debate: En Bloc Is Superior to Conventional TURBT for Initial Management of NMIBC

      Moderator: Peter Black – University of British Columbia

    • 10:30 - 10:38 GMT+0
      Pro

      Speaker: Jeremy Teoh – The Chinese University of Hong Kong

    • 10:38 - 10:46 GMT+0
      Con

      Speaker: Stephen B. Williams – University of Texas Medical Branch, USA, Texas

    • 10:46 - 10:55 GMT+0
      Discussions and Q&A

      Speaker: Jeremy Teoh – The Chinese University of Hong Kong

      Speaker: Stephen B. Williams – University of Texas Medical Branch, USA, Texas

      Moderator: Peter Black – University of British Columbia

    • 10:55 - 11:10 GMT+0
      Advances in Perioperative Therapy for Muscle-invasive Bladder Cancer
    • 11:10 - 11:45 GMT+0
      Case-Based Panel Discussion: Systemic therapy in metastatic bladder cancer

      Moderator: Kilian Martin Gust – Austria

      Panelist: Robert Jones – University of Glasgow

      Panelist: Daniele Raggi – The Royal Marsden Foundation Trust